HBK INVESTMENTS L P

Position in APGE — Apogee Therapeutics, Inc.

CIK 1011443 DALLAS, TX

Position in APGE

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$378,280,500

New position

Shares Held

2,850,000

first reported quarter

Ownership

3.77%

of shares outstanding

% of Portfolio

5.70%

of 13F equity value

Holder Rank

#3

of 285 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

HBK INVESTMENTS L P holds $861,082,950 across 5 Biotechnology names. APGE ranks #2 (43.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TECH	BIO-TECHNE Corp	6,825,000	$482,186,250
2	APGE	Apogee Therapeutics, Inc. This page	2,850,000	$378,280,500
3	HUMA	Humacyte, Inc.	790,000	$616,200
4			2,820,302	$0
5			3,483,100	$0

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$378,280,500	2,850,000	—	Shares	Sole	2026-08-14
No filing history on record for this holder in this stock.